Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas

Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort

(2019) Sashika Selvackadunco et al.   JOURNAL OF NEURAL TRANSMISSION

EEG-based neurophysiological indicators of hallucinations in Alzheimer's disease: Comparison with dementia with Lewy bodies

(2018) Meenakshi Dauwan et al.   NEUROBIOLOGY OF AGING

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies

(2017) Pai-Yi Chiu et al.   PLoS One

Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?

(2016) Soichiro Shimizu et al.   Geriatrics & Gerontology International

Novel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimization

(2016) Rajnish Kumar et al.   Scientific Reports

Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer’s disease

(2016) Frederic Blanc et al.   Alzheimers Research & Therapy

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

(2016) Ahmad A. Khundakar et al.   Acta Neuropathologica Communications

2015 Alzheimer's disease facts and figures

(2015)   Alzheimers & Dementia

Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia

(2015) Taya Thomas et al.   BRAIN

The relationship between hallucinations and FDG-PET in dementia with Lewy bodies

(2015) Michael J. Firbank et al.   Brain Imaging and Behavior

Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtype

(2015) Suzanne J. Reeves et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Autocrine Control of Angiogenesis by Endogenous Acetylcholine in an In Vitro Model Using Human Endothelial Cells

(2015) Stefan Dhein et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Clinical Features of Alzheimer Disease With and Without Lewy Bodies

(2015) Eun Joo Chung et al.   JAMA Neurology

Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia

(2014) Rachel Barker et al.   BRAIN

Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with Lewy Bodies

(2014) Scott Miners et al.   BRAIN PATHOLOGY

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations

(2014) Sandra A. Jacobson et al.   PARKINSONISM & RELATED DISORDERS

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease

(2014) Marta Swirski et al.   Alzheimers Research & Therapy

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1

(2014) J Scott Miners et al.   Acta Neuropathologica Communications

Assessing White Matter Ischemic Damage in Dementia Patients by Measurement of Myelin Proteins

(2013) Rachel Barker et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway

(2013) Swetha Vijayaraghavan et al.   PLoS One

Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial

(2012) Etsuro Mori et al.   ANNALS OF NEUROLOGY

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

(2012) Thomas G. Beach et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

(2012) Elizabeta B. Mukaetova-Ladinska et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cholinergic enhancement reduces functional connectivity and BOLD variability in visual extrastriate cortex during selective attention

(2012) Emiliano Ricciardi et al.   NEUROPHARMACOLOGY

Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease

(2012) T.J. Ferman et al.   PARKINSONISM & RELATED DISORDERS

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Efficacy and Comparative Effectiveness of Atypical Antipsychotic Medications for Off-Label Uses in Adults

(2011) Alicia Ruelaz Maher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The cerebrovascular role of the cholinergic neural system in Alzheimer's disease

(2010) Arenda H.E.A. Van Beek et al.   BEHAVIOURAL BRAIN RESEARCH

The cholinergic system and Parkinson disease

(2010) Nicolaas I. Bohnen et al.   BEHAVIOURAL BRAIN RESEARCH

Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies

(2010) T. Darreh-Shori et al.   Current Alzheimer Research

Visual Hallucinations in Dementia: A Prospective Community-Based Study With Autopsy

(2009) Debby Tsuang et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model

(2009) Yoshihiko Kakinuma et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

(2009) H. Shimada et al.   NEUROLOGY

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

(2007) Martin Steinberg et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine

(2006) T. Darreh-Shori et al.   NEUROBIOLOGY OF AGING